glp-1 brain inflammation Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure Glucagon-like peptide-1 (GLP-1) receptor agonists

Tirzepatide vs Semaglutide: Side Effects Like all GLP-1based therapies, both Tirzepatide and Semaglutide share a similar side effect profile, largely related to gastrointestinal tolerance

Code availability All codes described in the manuscript are available upon reasonable request to the corresponding authors

This article examines the relationship between GLP-1 therapy and dyspnea, reviews clinical evidence, and provides guidance on managing respiratory symptoms during treatment

Add to basket

In January, Novo Nordisks first oral version of Wegovy hit the marketplace, making it an option for individuals who may have been reluctant to use an injectable version, something that may make a difference for young people